FindTrial
Sign In

Study for clinical markers of bronchopulmonary dysplasia in neonates

Clinical study for sensitive plasma markers for corticosteroid therapy in bronchopulmonary dysplasia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033796
Enrollment
Unknown
Registered
2020-06-12
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchopulmonary dysplasia

Interventions

Sensitive, nonsensitive:corticosteroids

Sponsors

Huai'an First Hospital Affiliated to Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Gestational age =28 days after birth; 3. Infants requiring mechanical ventilation at 28 days old; 4. Blood tests such as PCT, CRP, blood culture, ß - glucan, endotoxin and other indicators of normal infants; 5. Sputum examination of Ureaplasma urealyticum and culture of normal infants.

Exclusion criteria

Exclusion criteria: 1. Patients with ventilator-associated pneumonia; 2. Patients (including dexamethasone, hydrocortisone, budesonide, etc.) who had used glucocorticoids before admission.

Design outcomes

Primary

MeasureTime frame
Plasma protein;—

Countries

China

Contacts

Public ContactTian Zhaofang

Huai'an First Hospital Affiliated to Nanjing Medical University

lyh0729@163.com+86 13905236862

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026